← FDA Drug Approvals (Drugs@FDA)

ERYTHROMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS CO · Approved 2018-03-09

Drug application

FDA Application #

ANDA209720

Application type

Abbreviated New Drug Application (Generic)

Brand name

ERYTHROMYCIN

Generic name

Erythromycin

Active ingredients

ERYTHROMYCIN

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

AMNEAL PHARMS CO

First approval

2018-03-09

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown